Xenform Postmarket Surveillance Study: A Prospective, Non-Randomized, Parallel Cohort, Multi-Center Study of Xenform vs. Native Tissue for the Treatment of Women with Anterior/Apical Pelvic Organ Prolapse

Sponsor

Boston Scientific Corporation

Principal Investigator

Dr. Catherine Matthews, Obstetrics and Gynecology

Project Run Dates

4/16/2014 to 5/31/2019

Total Award Amount

$220,500

 

Summary

To compare transvaginal repair with a biologic mesh to traditional native tissue repair in women surgically treated for anterior/apical pelvic organ prolapse with or without concurrent cystocele.

 

Associated Publications and other materials

Clinical Trials.gov

 

Associated Award Numbers: